AgenT is a company providing a blood test to detect and prevent Alzheimer's disease symptoms. Combining machine learning and neuroscience, the company develops specific blood biomarkers combinations for each stage of the disease. AgenT uses an algorithm aimed at detection of patients during the silent phase of Alzheimer's and stratifying them according to the disease progression. The company ailms to enable personalized medicine to prevent dementia.